RE: Leopard & spots !26 Jan 2023 10:14
We cannot assume that the "raise" rules out a potential 4m Biodefense grant. Hemo are still testing CBR on many viruses in secure Govt labs. The loan could not be used for CAR T, that would be CBR specific and I think decision making on that is March. Therefore, important money available now firstly for CBR for advancing this seminal platform in order to maintain lead and secondly to ensure funds needed for CAR T clinical trials. We would not want money set aside for CAR T being drained away for CBR such that neither progresses quickly. If we do not get the grant - there is at least, because of the raise, money for both. The science has not changed from yesterday but the MINT money carried us through to from 1.5 - to 3.7; this money will carry us from 2.5 to 6 ish perhaps. Important to note - we are a lot further on now. GLA